Moberg Pharma AB (publ) Cash Flow Reinvestment Rate
Moberg Pharma AB (publ) cash flow reinvestment rate. Moberg Pharma AB (publ) (MOB) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr1.52 Million (capex Skr1.52 Million ) from operating cash flow of Skr1.52 Million. Explore MOB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Moberg Pharma AB (publ) (2012–2019)
Cash flow reinvestment rate of Moberg Pharma AB (publ) from 2012 to 2019. Historical reinvestment intensity for Moberg Pharma AB (publ) across 6 annual periods. Explore Moberg Pharma AB (publ) (MOB) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Moberg Pharma AB (publ) Cash Flow Reinvestment Rate by Year (2012–2019)
Moberg Pharma AB (publ) cash flow reinvestment rate by year from 2012 to 2019. Year-by-year capital reinvestment analysis for Moberg Pharma AB (publ). For the full cash flow conversion analysis, see Moberg Pharma AB (publ) (MOB) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.73x | Skr2.87 Million | Skr3.95 Million | Skr2.87 Million | ▼ -67.9% |
| 2018 | 2.26x | Skr167.28 Million | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.73x | Skr39.35 Million | Skr53.82 Million | Skr19.68 Million | ▼ -48.8% |
| 2015 | 1.43x | Skr43.88 Million | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr7.27 Million | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr630.00K | Skr9.48 Million | Skr630.00K | — |